These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29748722)
21. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing. Greco K; Bogner R Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092 [TBL] [Abstract][Full Text] [Related]
22. Dissolution enhancement of carbamazepine using twin-screw melt granulation. Steffens KE; Wagner KG Eur J Pharm Biopharm; 2020 Mar; 148():77-87. PubMed ID: 31954840 [TBL] [Abstract][Full Text] [Related]
23. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions. Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178 [TBL] [Abstract][Full Text] [Related]
24. Hot-melt granulation in a twin screw extruder: effects of processing on formulations with caffeine and Ibuprofen. Weatherley S; Mu B; Thompson MR; Sheskey PJ; O'Donnell KP J Pharm Sci; 2013 Dec; 102(12):4330-6. PubMed ID: 24114922 [TBL] [Abstract][Full Text] [Related]
25. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. Boksa K; Otte A; Pinal R J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421 [TBL] [Abstract][Full Text] [Related]
26. Effect of protective colloids on the induction of polymorphic changes in indomethacin agglomerates after solvent evaporation from o/w emulsions. Lin SY; Chen KS; Teng HS J Microencapsul; 1999; 16(1):39-47. PubMed ID: 9972501 [TBL] [Abstract][Full Text] [Related]
27. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface. Zhang J; Shi Q; Guo M; Liu Z; Cai T Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128 [TBL] [Abstract][Full Text] [Related]
28. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide). Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764 [TBL] [Abstract][Full Text] [Related]
29. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions. Suzuki H; Iwata M; Ito M; Noguchi S Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659 [TBL] [Abstract][Full Text] [Related]
30. Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology. Gajera BY; Shah DA; Dave RH AAPS PharmSciTech; 2018 Nov; 19(8):3778-3790. PubMed ID: 30280356 [TBL] [Abstract][Full Text] [Related]
31. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816 [TBL] [Abstract][Full Text] [Related]
32. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. Crowley KJ; Zografi G J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208 [TBL] [Abstract][Full Text] [Related]
33. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900 [TBL] [Abstract][Full Text] [Related]
34. Melt granulation using a twin-screw extruder: a case study. Van Melkebeke B; Vermeulen B; Vervaet C; Remon JP Int J Pharm; 2006 Dec; 326(1-2):89-93. PubMed ID: 16949222 [TBL] [Abstract][Full Text] [Related]
35. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination. Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process. Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054 [TBL] [Abstract][Full Text] [Related]
38. Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. Liu H; Wang P; Zhang X; Shen F; Gogos CG Int J Pharm; 2010 Jan; 383(1-2):161-9. PubMed ID: 19748557 [TBL] [Abstract][Full Text] [Related]
39. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977 [TBL] [Abstract][Full Text] [Related]
40. Hot-melt extrusion process impact on polymer choice of glyburide solid dispersions: The effect of wettability and dissolution. Alshafiee M; Aljammal MK; Markl D; Ward A; Walton K; Blunt L; Korde S; Pagire SK; Kelly AL; Paradkar A; Conway BR; Asare-Addo K Int J Pharm; 2019 Mar; 559():245-254. PubMed ID: 30699365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]